pharmaphorum4 年
GSK steals march on AZ as FDA approves Trelegy in asthma
The FDA has approved GlaxoSmithKline’s Trelegy Ellipta inhaler for asthma in adults, adding to its existing use in chronic obstructive pulmonary disease (COPD), stealing a march on rivals ...
pharmaphorum6 年
FDA approves expanded use for GSK's COPD triple therapy
The FDA has approved an expanded label for GlaxoSmithKline’s new Trelegy Ellipta inhaler, allowing it to be used in a broader population of patients with chronic obstructive pulmonary disease ...